NCT03709186View on ClinicalTrials.gov

Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

September 1, 2020

Study Completion Date

January 1, 2021

Conditions
Invasive Breast Cancer
Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03709186 - Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI | Biotech Hunter | Biotech Hunter